RADLogics

RADLogics

Tel Aviv, Israel· Est.

AI‑powered retrospective imaging platform that identifies missed cancers in archived scans, starting with lung cancer on chest CTs.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

AI‑powered retrospective imaging platform that identifies missed cancers in archived scans, starting with lung cancer on chest CTs.

Oncology

Technology Platform

Patented AI engine that processes DICOM images with deep‑learning models to retrospectively detect cancers, delivering findings directly into existing clinical workflows.

Opportunities

Scaling retrospective AI analytics across additional imaging modalities and oncologic indications, and leveraging cloud partnerships to expand globally.

Risk Factors

Regulatory approval for AI medical devices, data privacy compliance, and competition from established AI imaging vendors.

Competitive Landscape

Competes with AI imaging firms such as Aidoc, Zebra Medical Vision, and Siemens Healthineers AI; differentiation lies in its focus on retrospective detection and seamless workflow integration without requiring new training.